Page 34 - 80_02
P. 34
Marlene
Marcelina
Saucedo--Balderas
&
al.
10.
AGRADECIMIENTOS
Al
Consejo
Nacional
de
Ciencia
y
Tecnología
de
México
(CONACyT)
por
el
financiamiento
(proyecto
179674)
otorgado.
11.
REFERENCIAS
1. Steed,
J.
W.;
Atwood,
J.
L.;
Supramolecular
Chemistry;Second
Ed;
John
Wiley
&
Sons,
Ltd.;
UK,
2009;
p
27.
2. Almarsson,
Ö.;
Zaworotko,
M.
J.
Crystal
engineering
of
the
composition
of
pharmaceutical
phases.
Do
pharmaceutical
co--crystals
represent
a
new
path
to
improved
medicines?
Chem.
Comm.7,
1889--1896
(2004).
3. Schultheiss,
N.;
Newman,
A.
Pharmaceutical
Cocrystals
and
Their
Physicochemical
Properties.
Cryst.
Growth
Des.9,
2950--2967
(2009).
4. Mirza,
S.;
Miroshnyk,
I.;
Heinämäki,
J.;
Yliruu,
J.
Co--crystals:
An
emerging
approach
for
enhancing
properties
of
pharmaceutical
solids.
Dosis24,
90--96
(2008).
5. Jones,
W.;
Motherwell,
W.
D.
S.;
Trask,
A.
V.
Pharmaceutical
Cocrystals:
An
Emerging
Approach
to
Physical
Property
Enhancement.
MRS
Bull.31,
875--879
(2006).
6. Sekhon,
B.
S.
Pharmaceutical
co--crystals
--
a
review.
ARS
Pharm.50,
99--117
(2009).
7. Herrera
Ruiz,
D.
¿Qué
sabe
Ud.
acerca
de…
los
co--cristales
farmacéuticos?
Rev.
Mex.
Cienc.
Farm.41,
55--56
(2010).
8. Delori,
A.;
Friscic,
T.;
Jones,
W.
The
role
of
mechanochemistry
and
supramolecular
design
in
the
development
of
pharmaceutical
materials.CrystEngComm14,
2350--2362
(2012).
9. Prasad,
R.
V.;
Rakesh,
M.
G.;
Jyotsna,
R.
M.;
Mangesh,
S.
T.;
Anita,
P.
S.;Mayur,
P.
K.
Pharmaceutical
Cocrystallization:
A
Review.
IJPCS.3,
725--736
(2012).
10. Friscic,
T.;
Jones,
W.
Recent
Advances
in
Understanding
the
Mechanism
of
Cocrystal
Formation
via
Grinding.
Cryst.
Growth
Des.9,
1621--1637
(2009).
11. Weyna,
D.
R.;
Shattock,
T.;
Vishweshwar,
P.;
Zaworotko,
M.
J.
Synthesis
and
Structural
Characterization
of
Cocrystals
and
Pharmaceutical
Cocrystals:
Mechanochemistryvs
Slow
Evaporation
from
Solution.
Cryst.
Growth
Des.9,
1106--1123
(2009).
12. Lin,
H.--L.;
Wu,
T.--K.;
Lin,
S.--Y.
Screening
and
characterization
of
cocrystal
formation
of
metaxalonewith
short--chain
dicarboxylic
acids
induced
by
solvent--assistedgrinding
approach.
Thermochim.
Acta575,
313--321
(2014).
13. Ober,
C.
A.;
Montgomery,
S.
E.;
Gupta,
R.
B.
Formation
of
itraconazole/L--malic
acid
cocrystals
by
gas
antisolventcocrystallization.
Powder
Technol.236,
122--131
(2013).
14. Aher,
S.;
Dhumal,
R.;
Mahadik,
K.;
Paradkar,
A.;
York,
P.
Ultrasound
assisted
cocrystallization
from
solution
(USSC)
containing
a
non--congruently
soluble
cocrystal
component
pair:
Caffeine/maleic
acid.
Eur.
J.
of
Pharm.
Sci.41,
597--602
(2010).
15. Padrela,
L.;
Rodrigues,
M.
A.;
Tiago,
J.;
Velaga,
S.
P.;
Matos,
H.
A.;
Azevedo,
E.
G.
Tuning
physicochemical
properties
of
theophylline
bycocrystallization
using
the
supercritical
fluid
enhancedatomization
technique.
J.of
Supercritical
Fluids86,
129--136
(2014).
16. Kojima,
T.;
Tsutsumi,
S.;
Yamamoto,
K.;
Ikeda,
Y.;
Moriwaki,
T.
High--throughput
cocrystal
slurry
screening
by
use
of
in
situ
Raman
microscopy
and
multi--well
plate.
Int.
J.
of
Pharm.399,
52--59
(2010).
17. Nanjwade,
V.
K.;
Manvi,
F.
V.;
Shamrez,
A.
M.;
Nanjwade,
B.
K.;Maste,
M.
M.
(2011).
New
Trends
in
the
Co--crystallization
of
Active
Pharmaceutical
Ingredients.J.
of
Appl.
Pharm.
Sci.1,
1--5.
18. Ali,
H.
R.
H.;
Alhalaweh,
A.;
Mendes,
N.
F.
C.;
Ribeiro--Claro,
P.;Velaga,
S.
P.
Solid--state
vibrational
spectroscopic
investigation
of
cocrystals
and
salt
of
indomethacin.
CrystEngComm.14,
6665--6674
(2012).
19. Castro,
R.
A.
E.;
Ribeiro,
J.
D.
B.;
Maria,
T.
M.
R.;
Silva,
M.
R.;
Yuste--Vivas,
C.;
Canotilho,
J.;
Eusebio,
M.
E.
S.
Naproxen
Cocrystals
with
Pyridinecarboxamide
Isomers.
Cryst.
Growth
Des.11,
5396--5404
(2011).
20. Bathori,
N.
B.;
Lemmerer,
A.;
Venter,
G.
A.;
Bourne,
S.
A.;
Caira,
M.
R.
Pharmaceutical
Co--
crystals
with
Isonicotinamide;Vitamin
B3,
Clofibric
Acid,
and
Diclofenac--and
Two
Isonicotinamide
Hydrates.
Cryst.
Growth
Des.11,
75--87
(2011).
272
